Effective management of chronic constipation (CC) and irritable bowel syndrome (IBS)-C involves a comprehensive strategy that includes a dynamic patient–provider relationship and a team approach among GI specialists, primary care practitioners, and allied healthcare professionals, as well as dietary changes, targeted pharmacotherapy; behavioral and psychosocial treatment; patient education; and ongoing monitoring and reassurance. This enduring activity will review the multitude of therapies available—and the clinical data supporting their use in the treatment of CC and IBS-C. Most importantly, this educational activity will describe sound, evidence-based strategies gastroenterologists can use to safely incorporate novel therapies and strategies into individualized treatment plans that acknowledge the heterogeneous nature of CC and IBS-C—and the patients they affect. Taken together, these measures should improve patient care and satisfaction and reduce the burden of disease.

• Describe the impact and prevalence of CC and IBS-C
• Discuss current evidence-based approaches to accurately characterize CC and IBS-C in order to differentiate them from other medical conditions that present with similar symptoms
• Formulate evidence-based treatment plans for patients with CC and IBS-C based on ongoing assessment of symptomatology

This activity has been designed to address the educational needs of physicians specializing in gastroenterology and other healthcare providers including Nurse Practitioners (NPs), and Physician Assistants (PAs) who manage and treat patients with CC and IBS-C.

Click here to register.

Physician Accreditation Statement

Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 1101021.